Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12


Research update for articles published in EJCI in 2016.

Adlbrecht C, Blanco-Verea A, Bouzas-Mosquera MC, Brion M, Burtscher M, Carbone F, Chang TT, Charmandari E, Chen JW, Correia-Costa L, Dullaart RPF, Eleftheriades M, Fernandez-Fernandez B, Goliasch G, Gremmel T, Groeneveld ME, Henrique A, Huelsmann M, Jung C, Lichtenauer M, Montecucco F, Nicolaides NC, Niessner A, Palmeira C, Pirklbauer M, Sanchez-Niño MD, Sotiriadis A, Sousa T, Sulzgruber P, van Beek AP, Veronese N, Winter MP, Yeung KK.

Eur J Clin Invest. 2018 Aug 12:e13016. doi: 10.1111/eci.13016. [Epub ahead of print] Review.


Acute calcium kinetics in haemodialysis patients.

Pirklbauer M, Schupart R, Mayer G.

Eur J Clin Invest. 2016 Dec;46(12):976-984. doi: 10.1111/eci.12680. Epub 2016 Oct 26.


Synergistic induction of CCL2/MCP-1 expression driven by oncostatin M and IL-1β in human proximal tubular cells depends on STAT3 and p65 NFκB/RelA.

Sarközi R, Corazza U, Osterkamp JP, Pirklbauer M, Mayer G, Schramek H.

Physiol Rep. 2015 Feb 22;3(2). pii: e12298. doi: 10.14814/phy2.12298. Print 2015 Feb 1.


FGF23 is associated with disease severity and prognosis in chronic heart failure.

Poelzl G, Trenkler C, Kliebhan J, Wuertinger P, Seger C, Kaser S, Mayer G, Pirklbauer M, Ulmer H, Griesmacher A.

Eur J Clin Invest. 2014 Dec;44(12):1150-8. doi: 10.1111/eci.12349. Epub 2014 Nov 3.


[DRESS syndrome following sulfasalazine treatment].

Pirklbauer M, Gruber J.

Z Rheumatol. 2014 Mar;73(2):180-3. doi: 10.1007/s00393-013-1308-5. German.


Oncostatin M inhibits TGF-β1-induced CTGF expression via STAT3 in human proximal tubular cells.

Sarközi R, Flucher K, Haller VM, Pirklbauer M, Mayer G, Schramek H.

Biochem Biophys Res Commun. 2012 Aug 10;424(4):801-6. doi: 10.1016/j.bbrc.2012.07.042. Epub 2012 Jul 16.


Oncostatin M is a novel inhibitor of TGF-β1-induced matricellular protein expression.

Sarközi R, Hauser C, Noppert SJ, Kronbichler A, Pirklbauer M, Haller VM, Grillari J, Grillari-Voglauer R, Mayer G, Schramek H.

Am J Physiol Renal Physiol. 2011 Nov;301(5):F1014-25. doi: 10.1152/ajprenal.00123.2011. Epub 2011 Aug 3.


The exchangeable calcium pool: physiology and pathophysiology in chronic kidney disease.

Pirklbauer M, Mayer G.

Nephrol Dial Transplant. 2011 Aug;26(8):2438-44. doi: 10.1093/ndt/gfr207. Epub 2011 May 5. Review.


CROOMA, complication rates of operatively treated mandibular fractures, paramedian and body.

Seemann R, Lauer G, Poeschl PW, Schicho K, Pirklbauer M, Russmüller G, Krennmair G, Perisanidis C, Ewers R, Klug C.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011 Apr;111(4):449-54. doi: 10.1016/j.tripleo.2010.06.008. Epub 2010 Oct 16.


Neuropilin-1 and neuropilin-2 are differentially expressed in human proteinuric nephropathies and cytokine-stimulated proximal tubular cells.

Schramek H, Sarközi R, Lauterberg C, Kronbichler A, Pirklbauer M, Albrecht R, Noppert SJ, Perco P, Rudnicki M, Strutz FM, Mayer G.

Lab Invest. 2009 Nov;89(11):1304-16. doi: 10.1038/labinvest.2009.96. Epub 2009 Sep 7.


Bortezomib-induced survival signals and genes in human proximal tubular cells.

Sarközi R, Perco P, Hochegger K, Enrich J, Wiesinger M, Pirklbauer M, Eder S, Rudnicki M, Rosenkranz AR, Mayer B, Mayer G, Schramek H.

J Pharmacol Exp Ther. 2008 Dec;327(3):645-56. doi: 10.1124/jpet.108.142604. Epub 2008 Sep 5.


TAMEE: data management and analysis for tissue microarrays.

Thallinger GG, Baumgartner K, Pirklbauer M, Uray M, Pauritsch E, Mehes G, Buck CR, Zatloukal K, Trajanoski Z.

BMC Bioinformatics. 2007 Mar 7;8:81.

Supplemental Content

Loading ...
Support Center